Search research articles
Contact Us
Filters
Showing results (51-60 of 114) with videos related to
Page
of 12
Sort By:
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 13, 2019
Health state utilities associated with treatment for transfusion-dependent β-thalassemia
Louis S Matza, L Clark Paramore, Katie D Stewart, et al.
Journal of Patient-Reported Outcomes
|
October 9, 2018
Development of the Diabetes Injection Device Experience Questionnaire (DID-EQ) and Diabetes Injection Device Preference Questionnaire (DID-PQ)
Louis S Matza, Kristina S Boye, Katie D Stewart, et al.
Journal of Patient-Reported Outcomes
|
October 9, 2018
Psychometric evaluation of the Diabetes Injection Device Experience Questionnaire (DID-EQ) and Diabetes Injection Device Preference Questionnaire (DID-PQ)
Louis S Matza, Katie D Stewart, Rosirene Paczkowski, et al.
Health and Quality of Life Outcomes
|
December 3, 2015
A qualitative examination of the content validity of the EQ-5D-5L in patients with type 2 diabetes
Louis S Matza, Kristina S Boye, Katie D Stewart, et al.
Obesity Science & Practice
|
August 7, 2023
Health state utilities associated with hyperphagia: Data for use in cost-utility models
Timothy A Howell, Louis S Matza, Usha G Mallya, et al.
Health and Quality of Life Outcomes
|
April 11, 2014
Impact of caregiver and parenting status on time trade-off and standard gamble utility scores for health state descriptions
Louis S Matza, Kristina S Boye, David H Feeny, et al.
The Journal of Nervous and Mental Disease
|
August 19, 2007
The patient experience of depression and remission: focus group results
Lori Frank, Louis S Matza, Jennifer Hanlon, et al.
International Psychogeriatrics
|
January 13, 2006
Validation of a new symptom impact questionnaire for mild to moderate cognitive impairment
Lori Frank, Jennifer A Flynn, Leah Kleinman, et al.
Health and Quality of Life Outcomes
|
October 13, 2006
Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes
Kristina Secnik Boye, Louis S Matza, Alan Oglesby, et al.
The Annals of Pharmacotherapy
|
September 25, 2009
Derivation and validation of the ASK-12 adherence barrier survey
Louis S Matza, Jinhee Park, Karin S Coyne, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 114) with videos related to
Sort By:
Page
of 12
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 13, 2019
Health state utilities associated with treatment for transfusion-dependent β-thalassemia
Louis S Matza, L Clark Paramore, Katie D Stewart, et al.
Journal of Patient-Reported Outcomes
|
October 9, 2018
Development of the Diabetes Injection Device Experience Questionnaire (DID-EQ) and Diabetes Injection Device Preference Questionnaire (DID-PQ)
Louis S Matza, Kristina S Boye, Katie D Stewart, et al.
Journal of Patient-Reported Outcomes
|
October 9, 2018
Psychometric evaluation of the Diabetes Injection Device Experience Questionnaire (DID-EQ) and Diabetes Injection Device Preference Questionnaire (DID-PQ)
Louis S Matza, Katie D Stewart, Rosirene Paczkowski, et al.
Health and Quality of Life Outcomes
|
December 3, 2015
A qualitative examination of the content validity of the EQ-5D-5L in patients with type 2 diabetes
Louis S Matza, Kristina S Boye, Katie D Stewart, et al.
Obesity Science & Practice
|
August 7, 2023
Health state utilities associated with hyperphagia: Data for use in cost-utility models
Timothy A Howell, Louis S Matza, Usha G Mallya, et al.
Health and Quality of Life Outcomes
|
April 11, 2014
Impact of caregiver and parenting status on time trade-off and standard gamble utility scores for health state descriptions
Louis S Matza, Kristina S Boye, David H Feeny, et al.
The Journal of Nervous and Mental Disease
|
August 19, 2007
The patient experience of depression and remission: focus group results
Lori Frank, Louis S Matza, Jennifer Hanlon, et al.
International Psychogeriatrics
|
January 13, 2006
Validation of a new symptom impact questionnaire for mild to moderate cognitive impairment
Lori Frank, Jennifer A Flynn, Leah Kleinman, et al.
Health and Quality of Life Outcomes
|
October 13, 2006
Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes
Kristina Secnik Boye, Louis S Matza, Alan Oglesby, et al.
The Annals of Pharmacotherapy
|
September 25, 2009
Derivation and validation of the ASK-12 adherence barrier survey
Louis S Matza, Jinhee Park, Karin S Coyne, et al.
Page
of 12